Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Aug 3;96(16):9033-8.
doi: 10.1073/pnas.96.16.9033.

Binding of elongin A or a von Hippel-Lindau peptide stabilizes the structure of yeast elongin C

Affiliations

Binding of elongin A or a von Hippel-Lindau peptide stabilizes the structure of yeast elongin C

M V Botuyan et al. Proc Natl Acad Sci U S A. .

Abstract

Elongin is a heterotrimeric transcription elongation factor composed of subunits A, B, and C in mammals. Elongin A and C are F-box-containing and SKP1 homologue proteins, respectively, and are therefore of interest for their potential roles in cell cycle-dependent proteolysis. Mammalian elongin C interacts with both elongin A and elongin B, as well as with the von Hippel-Lindau tumor suppressor protein VHL. To investigate the corresponding interactions in yeast, we have utilized NMR spectroscopy combined with ultracentrifugal sedimentation experiments to examine complexes of yeast elongin C (Elc1) with yeast elongin A (Ela1) and two peptides from homologous regions of Ela1 and human VHL. Elc1 alone is a homotetramer composed of subunits with a structured N-terminal region and a dynamically unstable C-terminal region. Binding of a peptide fragment of the Elc1-interaction domain of Ela1 or with a homologous peptide from VHL promotes folding of the C-terminal region of Elc1 into two regular helical structures and dissociates Elc1 into homodimers. Moreover, analysis of the complex of Elc1 with the full Elc1-interaction domain of Ela1 reveals that the Elc1 homodimer is dissociated to preferentially form an Ela1/Elc1 heterodimer. Thus, elongin C is found to oligomerize in solution and to undergo significant structural rearrangements upon binding of two different partner proteins. These results suggest a structural basis for the interaction of an F-box-containing protein with a SKP1 homologue and the modulation of this interaction by the tumor suppressor VHL.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Amino acid sequences and alignment of yeast Elc1 (Yeast C) with rat elongin C (Rat C) and yeast Skp1 (Yeast Skp1). (A) blast alignment of rat elongin C and yeast Elc1. Identical residues are indicated by a colon. Similar residues are indicated by a period. The symbols [ ], ( ), and { } indicate the sites in rat elongin C that were previously reported to be involved in elongin B binding, elongin A/B/C complex formation, and elongin A activation, respectively (13). (B) Alignment of yeast Skp1 with yeast Elc1. Identical residues are indicated by a colon. Similar residues are indicated by a period. The yeast Elc1 construct used in our studies has an additional three residues, GSH, at the N terminus for a total of 102 residues.
Figure 2
Figure 2
15N HSQC spectra of 15N-labeled Elc1. (A) Free. (B) VHL(157–171)-bound. (C) Ela1(1–143)-bound. (D) Ela1(3–17)-bound. Peaks assigned are labeled. Samples A, B, and D are 0.7–1.5 mM in 10 mM NaPi, pH 7.0/100 mM NaCl/10 μM ZnSO4/100 μM EDTA/7.5 mM DTT in 90% H2O/10% D2O. Sample C is 0.7 mM in similar buffer but at pH 7.5 and 500 mM NaCl. Experiments were run at 30°C (A, B, and D) or 25°C (C).
Figure 3
Figure 3
Plots of consensus CSI values for free Elc1 (A) and VHL(157–171)-bound Elc1 (B). CSI values of +1 reflect residues with helical backbone conformation, and values of −1 reflect regions with extended (β-type) backbone conformation. Unassigned residues are given the value of +0.2. Predicted helices are represented by coiled ribbons and β-strands by arrows.
Figure 4
Figure 4
Schematic representation of β-strand interactions in Elc1. Inter-strand long-range NOEs are indicated by arrows.

References

    1. Bradsher J N, Jackson K W, Conaway R C, Conaway J W. J Biol Chem. 1993;268:25587–25593. - PubMed
    1. Bradsher J N, Tan S, McLaury H-J, Conaway J W, Conaway R C. J Biol Chem. 1993;268:25594–25603. - PubMed
    1. Aso T, Lane W S, Conaway J W, Conaway R C. Science. 1995;269:1439–1443. - PubMed
    1. Garrett K P, Aso T P, Bradsher J N, Foundling S I, Lane W S, Conaway R C, Conaway J W. Proc Natl Acad Sci USA. 1995;92:7172–7176. - PMC - PubMed
    1. Duan D R, Pause A, Burgess W H, Aso T, Chen D Y, Garrett K P, Conaway R C, Conaway J W, Linehan W M, Klausner R D. Science. 1995;269:1402–1406. - PubMed

Publication types

MeSH terms